Clozapine carries the highest seizure risk of any antipsychotic, with reported rates ranging from about 1% to 10% depending on the dose used.1Clinical Psychopharmacology and Neuroscience. Low-dose Clozapine-induced Seizure: A Case Report Because clozapine remains the best-supported treatment for schizophrenia that has not responded to other medications, the goal is almost never to abandon the drug but to understand and manage the risk. That management hinges on dose, blood levels, titration speed, co-prescribed medications, and individual vulnerability factors that are worth knowing in detail.
How Common Are Clozapine-Related Seizures
The wide range in published incidence figures reflects the strong link between dose and risk. At low doses, seizures are uncommon. One review characterized seizures in patients taking 150 to 300 mg per day as “especially rare.”2PubMed Central. Low-dose clozapine-related seizure: A case report and literature review As daily doses climb above 600 mg, the incidence rises sharply. The overall estimate of roughly 1% to 10% spans the full dosing spectrum and includes patients on very high doses or with additional risk factors. For someone on a moderate, stable dose with no history of epilepsy, the real-world probability sits at the lower end of that range.
These numbers still make clozapine an outlier among antipsychotics. A Cochrane systematic review comparing clozapine head-to-head with other second-generation antipsychotics found that people taking clozapine experienced more seizures than those taking olanzapine or risperidone.3PubMed Central. Clozapine versus other atypical antipsychotics for schizophrenia A pharmacovigilance analysis of adverse-reaction reports likewise showed that clozapine accounted for a disproportionate share of seizure reports compared with both older and newer antipsychotics.4PubMed. Antipsychotics and seizures: higher risk with atypicals? None of this means other antipsychotics are seizure-free, but clozapine’s risk is clearly in a different category.
Why Dose and Blood Levels Matter So Much
Clozapine lowers the brain’s seizure threshold, meaning it makes neurons more excitable and easier to push into the kind of synchronized firing that produces a seizure. The effect is dose-dependent in a general sense: higher daily doses tend to produce higher blood concentrations of clozapine, and higher blood concentrations are associated with more seizures. But the relationship is not perfectly linear, because how much clozapine ends up in your bloodstream depends on your individual metabolism, liver enzyme activity, smoking status, and other medications.
A study of patients with treatment-resistant schizophrenia found that serum clozapine levels above 750 ng/mL were associated with roughly a five-fold increase in seizure odds.5PubMed. Possible drug-drug interaction between pregabalin and clozapine in patients with schizophrenia: clinical perspectives6International Clinical Psychopharmacology. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia A separate review identified case reports suggesting a very substantial risk once levels exceed 1,300 ng/mL, though useful data at those extremes was scarce.7Therapeutic Advances in Psychopharmacology. Clozapine-related EEG changes and seizures: dose and plasma-level relationships The practical takeaway is that monitoring blood levels gives clinicians a better picture of seizure risk than daily dose alone. Two patients on the same milligram dose can have dramatically different blood concentrations.
This is why routine blood draws are part of clozapine treatment. They are primarily required to monitor white blood cell counts (because of the separate risk of agranulocytosis), but the same blood sample can be used to check clozapine levels. When levels drift upward due to a new medication, a change in smoking habits, or an infection, the seizure threshold may drop before any warning signs appear.
How Fast You Go Up on the Dose
Speed of dose increases is an independent risk factor. Clozapine is typically started at a very low dose and raised gradually, in part because rapid upward titration has been linked to greater seizure risk.8PubMed. Clozapine-related seizures That slow climb creates a real clinical tension: patients with severe psychosis or agitation need an effective dose as soon as possible, and a gradual titration can mean weeks of inadequate treatment, sometimes requiring additional antipsychotics or prolonged hospitalization in the meantime.9PubMed Central. Risks and Benefits of Rapid Clozapine Titration
In practice, most prescribers follow a cautious schedule, adding no more than 25 to 50 mg every day or two during the initial weeks. Faster titration schedules do exist and have been tried in inpatient settings where patients can be closely monitored, but they carry a recognized trade-off. For someone hearing that their dose increase is going slowly, this is the reason: each step up gives the brain time to adjust to clozapine’s effects on neuronal excitability.
Seizures Can Look Different Than You Expect
When most people hear “seizure,” they picture the dramatic, full-body convulsion known as a generalized tonic-clonic seizure. Clozapine can certainly cause that type. But a study of ambulatory psychiatric patients who experienced clozapine-related seizures found a wider variety: some had generalized tonic-clonic seizures, others had myoclonic jerks (brief, involuntary muscle twitches), and still others had complex or simple partial seizures, which may involve confusion, staring, or unusual sensations without full-body convulsions.10PubMed. Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients
Myoclonic jerks in particular can go unrecognized or be mistaken for a side effect of sedation, clumsiness, or something unrelated. A patient who notices sudden, brief muscle twitches, especially at night or when falling asleep, should mention it to their prescriber. These jerks can be a sign that the seizure threshold has dropped and may precede a more serious event. The same is true for unexplained confusion or a “blank” spell lasting a few seconds.
EEG Changes Are Extremely Common but Misleading
This is one of the more counterintuitive aspects of clozapine treatment. If you were to hook up everyone on clozapine to an EEG (a recording of brain electrical activity), you would find abnormalities in a striking proportion. One cross-sectional study found EEG abnormalities in about 63% of clozapine-treated patients, with both slowing and epileptic-type activity present in over 40%.11PubMed Central. Electroencephalographic abnormalities in clozapine-treated patients: a cross-sectional study A prospective study at a fixed dose of 300 mg per day found the same rate, about 64%, with epileptic activity showing up on the EEG of some patients who never went on to have a clinical seizure.12European Neuropsychopharmacology. EEG abnormalities in clozapine-treated schizophrenic patients
The critical point is that EEG abnormalities during clozapine treatment do not reliably predict who will actually have a seizure.13European Neuropsychopharmacology. EEG abnormalities in clozapine-treated schizophrenic patients Another study over a ten-week period found EEG changes in about 53% of patients, with spikes appearing in 13% that had no relationship to dose or blood levels.14PubMed. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels This means a routine EEG might show alarming-looking activity that does not translate into clinical risk, leading some clinicians to avoid routine EEG screening and instead reserve it for patients who have specific risk factors or who have already had a seizure.
Current expert opinion holds that an EEG is not routinely required before or during clozapine treatment, but it can be useful in specific situations: someone with a pre-existing brain injury, a known seizure disorder, or an episode that might have been a seizure. In those cases, an EEG combined with clozapine blood levels can help the clinical team decide whether to reduce the dose or add a protective anticonvulsant.15Clinical Psychopharmacology and Neuroscience. Clozapine Monitoring in Clinical Practice: Beyond the Mandatory Requirement
Who Is at Higher Risk
Beyond dose and blood levels, several patient-level factors raise the likelihood of a clozapine-related seizure:
- Pre-existing seizure disorder: Someone who has had seizures before, from any cause, has a lower seizure threshold to begin with. Clozapine pushes it further down.
- Neurological abnormalities: Structural brain changes from injury, stroke, or developmental conditions increase vulnerability.
- Epileptogenic medications: Some other drugs also lower the seizure threshold. Taking them alongside clozapine compounds the risk.16Clinical Psychopharmacology and Neuroscience. Low-dose Clozapine-induced Seizure: A Case Report
It is worth noting that seizures can still occur in people with none of these risk factors. Case reports document tonic-clonic seizures in patients on low-dose clozapine who had no prior seizure history and no identifiable neurological problems.17Clinical Psychopharmacology and Neuroscience. Low-dose Clozapine-induced Seizure: A Case Report One case involved a patient on 300 mg per day with normal brain imaging and blood work who developed seizures; reducing the dose to 250 mg resolved the problem, but re-increasing the dose brought the seizures back.18PubMed Central. Clozapine-induced seizure Cases like these underscore that while risk factors help predict who is more likely to have a seizure, no one on clozapine is fully exempt.
Drug Interactions That Raise the Risk
Adding other medications to clozapine can push seizure risk higher through two main pathways: by raising clozapine blood levels or by independently lowering the seizure threshold.
A pharmacovigilance analysis using global adverse-reaction data found that several other antipsychotics, when used alongside clozapine, were associated with increased seizure reports. The list included haloperidol, olanzapine, risperidone, chlorpromazine, and several others. The researchers found a statistical link between how strongly the co-prescribed antipsychotic binds to a specific dopamine receptor subtype and the strength of the seizure signal.19PubMed Central. Seizures associated with clozapine augmentation by other antipsychotics: a pharmacovigilance-pharmacodynamic analysis using VigiBase In plain terms, adding a second antipsychotic to clozapine is not a neutral move with respect to seizure risk, and the combination may be more dangerous than either drug alone.
Other medications have been flagged too. Pregabalin, a drug used for nerve pain and anxiety, was implicated in a case series where patients on clozapine experienced falls and fractures, with one patient having confirmed seizures and clozapine blood levels likely elevated by the interaction.20PubMed. Possible drug-drug interaction between pregabalin and clozapine in patients with schizophrenia: clinical perspectives Any medication that inhibits the liver enzymes responsible for breaking down clozapine can effectively give you a higher dose than what the prescription says, because more of the drug accumulates in your blood. Common culprits include certain antibiotics, antifungals, and the antidepressant fluvoxamine. Meanwhile, quitting smoking (which speeds up clozapine metabolism through enzyme induction) can cause blood levels to rise by 50% or more, sometimes catching patients and prescribers off guard.
Managing Seizures Without Stopping Clozapine
Because clozapine is the strongest evidence-based treatment for schizophrenia that has resisted other medications, stopping it after a seizure can mean returning a patient to inadequately treated psychosis. The standard clinical approach, supported by expert consensus, is to try to continue clozapine while addressing the seizure risk.21PubMed. Seizure associated with clozapine: incidence, etiology, and management The first step is usually reducing the dose and checking blood levels. If a dose reduction alone is not enough, or if the patient needs to stay at a higher dose for psychiatric stability, an anticonvulsant is added.
Valproate (valproic acid, sometimes sold as Depakote) is generally considered the first-choice anticonvulsant for clozapine-related seizures.22PubMed Central. Medications for Managing Clozapine-Related Seizures and Stuttering It raises the seizure threshold without substantially interfering with clozapine’s metabolism. Lamotrigine is considered the second option, with case reports supporting its successful use when valproate is not tolerated or not effective.23PubMed. Use of lamotrigine in a patient with a clozapine-related seizure Gabapentin and topiramate have also been used successfully in individual cases.24PubMed. Seizure associated with clozapine: incidence, etiology, and management
An important caveat about prevention: anticonvulsants are not recommended as a blanket preventive measure for everyone starting clozapine. They are reserved for patients who have already experienced a seizure (secondary prophylaxis) or who are judged to be at particularly high risk. This distinction matters because every additional medication brings its own side effects and interactions.25PubMed. Use of anticonvulsants as prophylaxis for seizures in patients on clozapine When anticonvulsants are used, the choice must account for how the drug interacts with clozapine’s blood levels. Some anticonvulsants can push clozapine levels up or down in ways that either increase side effects or reduce the psychiatric benefit.
Anticonvulsants to Avoid
Carbamazepine deserves special mention because it is one of the most widely prescribed anticonvulsants for epilepsy but is effectively off-limits for patients on clozapine. Both carbamazepine and clozapine can independently suppress white blood cell production, and combining them raises the risk of agranulocytosis, a potentially fatal drop in infection-fighting cells.26PubMed Central. Are clozapine blood dyscrasias associated with concomitant medications? Since clozapine already requires regular blood monitoring for this very side effect, adding a drug that worsens it is generally avoided unless no alternative exists.
Phenytoin is another anticonvulsant that is sometimes flagged, less because of blood cell concerns and more because it is a strong inducer of the liver enzymes that break down clozapine. Adding phenytoin can cause clozapine blood levels to drop, potentially undermining psychiatric stability and paradoxically requiring higher clozapine doses that re-raise seizure risk. This interplay between anticonvulsant choice, clozapine metabolism, and white blood cell safety is why seizure management in clozapine patients is more complicated than simply picking the most common anti-seizure drug off the shelf.
When Seizures Happen at Low Doses
Most discussions of clozapine seizures emphasize the dose-dependent nature of the risk, and for good reason: the majority of seizures occur at higher doses. But the published literature includes scattered case reports of seizures at daily doses well within the low-to-moderate range (150 to 300 mg), sometimes in patients with no identifiable risk factors at all.27PubMed Central. Low-dose clozapine-related seizure: A case report and literature review These cases are rare enough to be published individually, which itself tells you something about how unusual they are, but they complicate the reassuring narrative that low dose equals low risk.
What explains them? In some cases, a pharmacokinetic quirk may be at work: the patient metabolizes clozapine unusually slowly, so even a modest dose produces blood levels more typical of someone on a much higher dose. In other cases, no clear explanation has been found. Clinicians who treat these patients typically check blood levels immediately after a seizure, because a surprisingly high level points to a metabolic cause that can be addressed by lowering the dose. When blood levels are unremarkable, the decision becomes harder: reduce a dose that may already be barely adequate for the patient’s psychiatric symptoms, or add an anticonvulsant and continue.
Clozapine’s Unique Position in Psychiatry
Understanding the seizure risk in proper context requires recognizing why clozapine is prescribed at all despite its demanding side-effect profile. It is the only antipsychotic with strong evidence of efficacy in treatment-resistant schizophrenia, a condition defined by failure to improve on at least two adequate trials of other antipsychotics.28PubMed Central. Low-dose clozapine-related seizure: A case report and literature review For the roughly 30% of people with schizophrenia who meet that definition, clozapine is not one option among many. It is the option. Stopping it because of a manageable side effect can leave someone with untreated psychosis, which carries its own serious risks.
That is why the literature on clozapine seizures consistently frames the discussion around continuation rather than discontinuation. After a seizure occurs, expert guidance calls for every effort to manage the side effect and keep the patient on clozapine, using dose adjustments, anticonvulsants, and blood-level monitoring as tools.29PubMed. Seizure associated with clozapine: incidence, etiology, and management Well-designed clinical trials specifically on clozapine seizure prophylaxis are still lacking, which means clinicians are largely working from case reports, clinical experience, and extrapolation from the general epilepsy literature. It is an area where the research has not caught up to the clinical need, and prescribing decisions often come down to careful, individualized judgment rather than clear algorithmic guidance.